Cargando…

ODP598 Liquid levothyroxine (L-T4) maintains more stable TSH levels in hypothyroid patients, than tablet L-T4

Hypothyroidism affects approximately 5% of the population, mostly women and people over 60 years of age. The standard therapy used for the treatment of hypothyroidism is tablet levothyroxine (L-T4). Thyroid-stimulating hormone (TSH) is monitored, and L-T4 is adjusted as necessary to reach euthyroidi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antonelli, Alessandro, Balestri, Eugenia, Botrini, Chiara, Elia, Giusy, Ferrari, Silvia Martina, Mazzi, Valeria, Paparo, Sabrina Rosaria, Patrizio, Armando, Ragusa, Francesca, Fallahi, Poupak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627740/ http://dx.doi.org/10.1210/jendso/bvac150.1642

Ejemplares similares

PSAT366 Liquid L-thyroxine (L-T4) Formulation Normalizes TSH in Hypothyroid Patients Treated with Tablets L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

MON-LB102 Liquid L-Thyroxine Can Maintain Stable TSH Values in Patients with Hypothyroidism: A Prospective Study
por: Fallahi, Poupak, et al.
Publicado: (2019)

FRI487 Oral Liquid L- Thyroxine (L-T4) Is More Effective In Controlling Hypothyroidism, Than L-T4 Tablet, In Patients Submitted To Total Thyroidectomy
por: Fallahi, Poupak, et al.
Publicado: (2023)

MON-625 Serum Tsh Levels Normalisation In Patients With Celiac Disease After The Switch From Oral L-t4 In Tablet Form To L-t4 In Liquid Formulation
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Oral Liquid L-Thyroxine (L-T4) May Be Better Absorbed in Comparison to L-T4 Tablets in Patients With Lactose Intolerance
por: Fallahi, Poupak, et al.
Publicado: (2021)

FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2023)

ODP490 Levothyroxine Dosing Based on BMI and Different Causes of Hypothyroidism
por: Darquea, Andres, et al.
Publicado: (2022)

MON-564 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With L-thyroxine (L-T4) In Soft Gel Capsule Formulation
por: Fallahi, Poupak, et al.
Publicado: (2019)

The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

MON-601 Optimizing the Mean TSH Target Range for Thyroid Hormone (L-T4) Replacement in Primary Hypothyroidism
por: Siddiqui, Mahwash, et al.
Publicado: (2019)

ODP476 Does Levothyroxine Intake at Breakfast Matter for Patients With Hypothyroidism? A Meta- Analysis of Randomized Control Trials
por: Cheng, Ce, et al.
Publicado: (2022)

ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
por: Trusty, Rhonda-Kaye, et al.
Publicado: (2022)

MON-565 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With Oral Liquid L-thyroxine (L-T4) Formulation
por: Fallahi, Poupak, et al.
Publicado: (2019)

Development of Intranasal Levothyroxine Powder Delivery for Hypothyroidism
por: Imran, Syed Ali, et al.
Publicado: (2021)

MON-623 Higher FT4 Results in Levothyroxine-Treated Patients with Normal TSH Compared to Patients without Thyroid Disease
por: Galior, Kornelia, et al.
Publicado: (2019)

Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series
por: Fallahi, Poupak, et al.
Publicado: (2022)

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021)

ODP511 Relationship between TSH and Free Thyroxine in Outpatient Cancer Patient Population
por: Li, Jieli, et al.
Publicado: (2022)

ODP529 Update on the Prevalence and Pathogenesis of Central Hypothyroidism
por: Heshmati, Hassan M, et al.
Publicado: (2022)

ODP533 Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

L-T4 Therapy in Enteric Malabsorptive Disorders
por: Fallahi, Poupak, et al.
Publicado: (2021)

ODP513 Rhabdomyolysis: A Rare Presentation Of Central hypothyroidism
por: Humphries, Derrek, et al.
Publicado: (2022)

Oral L‐thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study
por: Fallahi, Poupak, et al.
Publicado: (2018)

Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism
por: Ferrari, Silvia Martina, et al.
Publicado: (2021)

ODP460 Age- and sex- specific reference ranges for serum thyrotropin (TSH), free T4 and free T3 levels: Significant effects on the definition of subclinical dysfunction
por: Yamada, Sayaka, et al.
Publicado: (2022)

MON-594 Report Of A Large Series Of Patients With Graves' Disease (with/without Graves' Ophthalmopathy) And Review Of The Literature, About The Association With Other Autoimmune Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

SAT-503 Levothyroxine Absorption Testing in Three Patients with Severe Hypothyroidism on Adequate Replacement
por: Martinez, Eduardo Andres Lopez, et al.
Publicado: (2020)

SAT-425 Characteristics of Hypothyroid Patients Achieving Long Term Euthyroidism on Levothyroxine Treatment
por: Tandeter, Howard, et al.
Publicado: (2020)

Stopping Levothyroxine Therapy in Subclinical Hypothyroidism, Perhaps We Could Start a Trend
por: Albashaireh, Arwa, et al.
Publicado: (2021)

ODP534 Repercussions of Thyroid Autoimmunity on Neonatal Outcomes in Pregnant Hypothyroid Women
por: Athar, Sufia, et al.
Publicado: (2022)

ODP486 Hypothyroidism And Its Relation To Clinical Outcome In Covid-19 Inpatients
por: Rech, Carolina Leães, et al.
Publicado: (2022)

Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer
por: Ragusa, Francesca, et al.
Publicado: (2022)

Molecular features of aggressive thyroid cancer
por: Elia, Giusy, et al.
Publicado: (2022)

Myoinositol in Autoimmune Thyroiditis
por: Paparo, Sabrina Rosaria, et al.
Publicado: (2022)

ODP517 Successful Treatment of Myxedema Coma after SARS-CoV-2 infection with Combination Oral Levothyroxine and Liothyronine
por: Dimayuga, Diana Colleen, et al.
Publicado: (2022)

ODP459 Adiposity Rebound in Japanese Patients with Congenital Hypothyroidism Detected by Neonatal Screening
por: Nakayama, Kanako, et al.
Publicado: (2022)

ODP500 Nephrotic syndrome as a cause of worsening hypothyroidism due to Hashimoto's thyroiditis
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

ODP504 PERICARDIAL EFFUSION AS A LIKELY CONSEQUENCE OF NON-COMPLIANT MANAGEMENT OF HYPOTHYROIDISM
por: Rimal, Priya, et al.
Publicado: (2022)

ODP453 A Lady Changes from Hypothyroid to Hyperthyroid State during Pregnancy
por: Ho, Cheuk Wah
Publicado: (2022)

ODP615 Emergence of Graves’ Ophthalmopathy in the Setting of Sudden Hypothyroidism: Possible Mechanisms Explored
por: Suelto, Jeremy Anne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ap1difeieads28t8jnonnvsdhp